Tenax Therapeutics Inc (TENX)
3.55
0.00 (0.00%)
USD |
NASDAQ |
May 17, 16:00
3.66
+0.11
(+3.10%)
After-Hours: 20:00
Tenax Therapeutics Market Cap: 6.952M for May 17, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| May 16, 2024 | 6.952M |
| May 15, 2024 | 7.030M |
| May 14, 2024 | 6.795M |
| May 13, 2024 | 6.952M |
| May 10, 2024 | 7.020M |
| May 09, 2024 | 6.991M |
| May 08, 2024 | 6.952M |
| May 07, 2024 | 6.912M |
| May 06, 2024 | 7.265M |
| May 03, 2024 | 7.520M |
| May 02, 2024 | 7.422M |
| May 01, 2024 | 7.637M |
| April 30, 2024 | 7.637M |
| April 29, 2024 | 7.187M |
| April 26, 2024 | 6.814M |
| April 25, 2024 | 7.050M |
| April 24, 2024 | 6.971M |
| April 23, 2024 | 6.854M |
| April 22, 2024 | 6.971M |
| April 19, 2024 | 7.108M |
| April 18, 2024 | 7.206M |
| April 17, 2024 | 7.030M |
| April 16, 2024 | 7.069M |
| April 15, 2024 | 7.059M |
| April 12, 2024 | 7.363M |
| Date | Value |
|---|---|
| April 11, 2024 | 7.578M |
| April 10, 2024 | 7.578M |
| April 09, 2024 | 7.676M |
| April 08, 2024 | 7.774M |
| April 05, 2024 | 7.480M |
| April 04, 2024 | 7.480M |
| April 03, 2024 | 8.048M |
| April 02, 2024 | 7.578M |
| April 01, 2024 | 7.480M |
| March 28, 2024 | 8.303M |
| March 27, 2024 | 7.578M |
| March 26, 2024 | 7.265M |
| March 25, 2024 | 7.245M |
| March 22, 2024 | 7.480M |
| March 21, 2024 | 7.676M |
| March 20, 2024 | 7.539M |
| March 19, 2024 | 6.746M |
| March 18, 2024 | 6.870M |
| March 15, 2024 | 6.622M |
| March 14, 2024 | 6.746M |
| March 13, 2024 | 6.905M |
| March 12, 2024 | 7.064M |
| March 11, 2024 | 7.082M |
| March 08, 2024 | 7.17M |
| March 07, 2024 | 7.117M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
1.742M
Minimum
Feb 09 2024
56.12M
Maximum
Jun 28 2021
14.74M
Average
8.602M
Median
Aug 06 2019
Market Cap Benchmarks
| CEL-SCI Corp | 70.17M |
| AIM ImmunoTech Inc | 20.41M |
| IGC Pharma Inc | 35.83M |
| NovaBay Pharmaceuticals Inc | 4.494M |
| Protalix BioTherapeutics Inc | 83.95M |
Market Cap Related Metrics
| Price to Book Value | 0.8584 |
| Price | 3.55 |
| Earnings Yield | -964.5% |